Search Results 1-10 of 15648 for Residual

1. Residual limb pain - Diagnosis and treatment - Mayo Clinic

   Diagnosis · Physical exam. A healthcare professional feels the residual arm or leg to check for issues in the skin or bones. · Imaging tests. MRI, CT, X-rays or ...

2. Residual limb pain - Symptoms and causes - Mayo Clinic

   Overview. Residual limb pain is a type of pain felt in the part of an arm or leg that's left after the arm or leg is removed, called amputation.

3. COVID-19 Residual Biobank (Enrolling by Invitation Only) - Mayo Clinic

   The purpose of this study is to collect residual (waste) blood, urine, and stool specimens remaining from clinician order testing and corresponding clinical and ...

4. Surgical Drain Fluid for Detection of Molecular Residual Disease (MRD) in Bladder, Renal and Urothelial Cancers - Mayo Clinic

   Surgical Drain Fluid for Detection of Molecular Residual Disease (MRD) in Bladder, Renal and Urothelial Cancers · Overview · Participation eligibility.

5. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR) - Mayo Clinic

   cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR) ... residual disease and recurrence.

6. A Study to Evaluate the Surgical Removal of Residual Brain Tumors Prior to Recurrence - Mayo Clinic

   Eligible patients with surgically accessible latent tumors desiring surgical resection will be enrolled to prospectively track short- and long-term outcomes.

7. Surgical Drain Fluid for Detection of Molecular Residual Disease for HPV(-) Head and Neck Cancers - Mayo Clinic

   Surgical Drain Fluid for Detection of Molecular Residual Disease for HPV(-) Head and Neck Cancers ... residual disease (MRD) with clinical, radiographic ...

8. Surgical Drain Fluid for Detection of Molecular Residual Disease in Patients With Non-small Cell Lung Cancers - Mayo Clinic

   Surgical Drain Fluid for Detection of Molecular Residual Disease in Patients With Non-small Cell Lung Cancers · Overview · Participation eligibility.

9. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL - Mayo Clinic

   The purpose of this study is to evaluate the rate of complete MRD response by flow cytometry after 4 weekly doses of daratumumab-hyaluronidase (Day 29) among ...

10. A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants.